Keyword: Fred Hutchinson Cancer Research Center
The week’s biotech news included a potential boost to cancer immunotherapy and new insight into a dementia-causing protein.
Recent biotech discoveries include a sensory protein at the heart of hearing and new insights into how CAR-T design affects cancer treatments.
More details on Amazon’s secret skunk-works research division have been revealed, including work in cancer research and EHRs, in reports from CNBC.
The ability to manipulate genes known to play a role in HIV resistance could help eliminate dormant reservoirs of virus that can resurge at any time.
Biotech developments over the past week include promising data from a human trial of male contraception and a new strategy to protect against malaria.
Takeda has added another early-stage research partnership as it reboots its R&D operations, this time teaming with two Seattle-based academic centers.
The past week saw news of a partnership aimed at improving cancer discovery, a technique for reversing heart damage and a new cancer-killing cell.
Fred Hutchinson scientists have identified biomarkers associated with dangerous side effects possible in cancer patients treated with CAR-T cells.
The agreement gives the Fortress Biotech offshoot a phase 1/2-ready cell therapy to advance alongside its existing clutch of CAR-Ts.
Fred Hutch scientists have created nanoparticles that could address shortcomings associated with CAR-T cancer treatments.